BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30147693)

  • 41. COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency.
    Ponsford MJ; Shillitoe BMJ; Humphreys IR; Gennery AR; Jolles S
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):525-534. PubMed ID: 34596095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia.
    Martignani C; Massaro G; Bruno AG; Biffi M; Ziacchi M; Diemberger I
    Immunobiology; 2020 Jan; 225(1):151861. PubMed ID: 31740078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia.
    Amedei A; Romagnani C; Benagiano M; Azzurri A; Fomia F; Torrente F; Plebani A; D'Elios MM; Del Prete G
    Eur J Immunol; 2001 Jun; 31(6):1927-34. PubMed ID: 11433390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes.
    Pérez de Diego R; López-Granados E; Pozo M; Rodríguez C; Sabina P; Ferreira A; Fontan G; García-Rodríguez MC; Alemany S
    J Allergy Clin Immunol; 2006 Jun; 117(6):1462-9. PubMed ID: 16751014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MAP kinase p38α regulates type III interferon (IFN-λ1) gene expression in human monocyte-derived dendritic cells in response to RNA stimulation.
    Jiang M; Österlund P; Fagerlund R; Rios DN; Hoffmann A; Poranen MM; Bamford DH; Julkunen I
    J Leukoc Biol; 2015 Feb; 97(2):307-20. PubMed ID: 25473098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia.
    Sochorová K; Horváth R; Rozková D; Litzman J; Bartunková J; Sedivá A; Spísek R
    Blood; 2007 Mar; 109(6):2553-6. PubMed ID: 17090647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Splice-correction strategies for treatment of X-linked agammaglobulinemia.
    Bestas B; Turunen JJ; Blomberg KE; Wang Q; Månsson R; El Andaloussi S; Berglöf A; Smith CI
    Curr Allergy Asthma Rep; 2015 Mar; 15(3):510. PubMed ID: 25638286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
    Kong X; Mo G; Liu N; Tian P; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
    Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
    Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
    Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
    Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia.
    Mohammad T; Amir M; Prasad K; Batra S; Kumar V; Hussain A; Rehman MT; AlAjmi MF; Hassan MI
    Int J Biol Macromol; 2020 Dec; 164():2399-2408. PubMed ID: 32784026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential application of gene therapy to X-linked agammaglobulinemia.
    Moreau T; Calmels B; Barlogis V; Michel G; Tonnelle C; Chabannon C
    Curr Gene Ther; 2007 Aug; 7(4):284-94. PubMed ID: 17969561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
    Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
    Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An X-linked agammaglobulinemia (XLA) patient with fever and disturbance of consciousness: infection with Torque teno virus?
    Liu H; Zhao J; Yang L; Yang C; Liu Y
    Int J Infect Dis; 2022 Feb; 115():26-29. PubMed ID: 34863924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils.
    Broides A; Hadad N; Levy J; Levy R
    J Clin Immunol; 2014 Jul; 34(5):555-60. PubMed ID: 24771458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in btk in patients with presumed X-linked agammaglobulinemia.
    Conley ME; Mathias D; Treadaway J; Minegishi Y; Rohrer J
    Am J Hum Genet; 1998 May; 62(5):1034-43. PubMed ID: 9545398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia.
    González-Serrano ME; Estrada-García I; Mogica-Martínez D; González-Garay A; López-Herrera G; Berrón-Ruiz L; Espinosa-Padilla SE; Yamazaki-Nakashimada MA; Vargas-Hernández A; Santos-Argumedo L; Estrada-Parra SA; Espinosa-Rosales FJ
    J Clin Immunol; 2012 Oct; 32(5):967-74. PubMed ID: 22665224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.